Estrogen therapy increases benign breast disease risk

Courtesy EurekAlert! - Cancer  Mon, 04/07/2008 - 23:00

Women who took conjugated equine estrogen, a commonly prescribed form of estrogen, had more than twice the risk of developing specific types of benign breast disease as women who took a placebo, according to a randomized controlled trial published online April 8 in the Journal of the National Cancer Institute.

Sponsors
Tags:

 

Related news items

Also in the August 12 JNCI
(Journal of the National Cancer Institute) The August 12 online issue of the Journal of the National Cancer Institute also includes an analysis of...

Risk assessment plays key role in long-term treatment of breast ...
(University of Texas M. D. Anderson Cancer Center) Breast cancer patients and their physicians may make more informed, long-term treatment decisions...

Also in the June 24 JNCI
(Journal of the National Cancer Institute) Also in the June 24 issue of JNCI are a study identifying a tumor suppressor gene associated with...

Review of cervical cancer screening program shows effectiveness ...
(Journal of the National Cancer Institute) Women who do not undergo regular cervical cancer screening tests are more likely to be diagnosed with the...

Other highlights in the April 29 JNCI
(Journal of the National Cancer Institute) Also in the April 29 JNCI are a mathematical model to predict response to tamoxifen, stem cell-like cancer...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com